AG真人官方

Cardinal Health (CAH) Form 144 notice reports a proposed sale of 21,367 common shares through Merrill Lynch on 08/20/2025 with an aggregate market value of $3,216,330.00. The filing shows the shares were acquired on 08/15/2025 from Cardinal Health, Inc. as 13,088 shares from performance stock vesting and 8,279 shares from restricted stock vesting. No securities were reported sold by the same person in the past three months. The document includes the required representation that the seller is not aware of undisclosed material adverse information and references potential Rule 10b5-1 plan considerations.

Insider sale by Cardinal Health officer: The Form 4 shows Deborah Weitzman, identified as an officer (CEO, PSS Segment), sold 21,367 common shares on 08/20/2025 at a weighted average price of $150.53 per share (sales ranged $150.22 to $151.00). After the reported dispositions she beneficially owned 53,428 shares. The filing notes the weighted-average price and offers to provide detailed per-trade quantities and prices on request. No derivative transactions or additional acquisitions are reported in this Form 4.

Insider transactions reported for Cardinal Health, Inc. (CAH). The Form 4 shows Jason M. Hollar, listed as Chief Executive Officer and an officer reporting person, sold common shares on 08/20/2025 in two separate sets of transactions. The first sale disposed of 12,944 shares at a weighted average price of $149.40, leaving 222,957 shares beneficially owned. The second sale disposed of 22,957 shares at a weighted average price of $150.40, leaving 200,000 shares beneficially owned following that reported transaction.

The filings note the prices are weighted averages from multiple trades within specified ranges and state the reporting person will provide further breakdowns on request. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Mary C. Scherer, Chief Accounting Officer of Cardinal Health, Inc. (CAH), reported multiple transactions on Form 4. She was granted 1,203 restricted stock units (RSUs) on 08/15/2025 that vest in three equal annual installments beginning 08/15/2026. To satisfy tax withholding on vested awards, 2,572 shares were withheld (reported as a disposition at $150.22, reflecting prior close). Separately, 6,766 common shares were sold on 08/19/2025 at a weighted average price of $149.25, with sale prices ranging $148.94鈥�$149.60. After these transactions her reported beneficial ownership of common shares is 3,556 shares.

Cardinal Health insider filings show multiple equity transactions by Michelle D. Greene, the company's Chief Information Officer. On 08/15/2025 Greene received a grant of 3,476 restricted share units (RSUs) that vest in three equal annual installments beginning 08/15/2026. The filing also discloses withholding of 9,968 shares to satisfy taxes related to the vesting of 6,787 RSUs and 16,362 performance share units, using a prior-business-day closing price of $150.22. On 08/19/2025 Greene sold a total of 13,500 common shares in multiple transactions at weighted-average prices of $148.76 and $149.28, reducing beneficial ownership from 38,444 to 14,976 shares.

Mason Stephen M, an officer (CEO, GMPD Segment) of Cardinal Health, Inc. (CAH), reported multiple transactions in the companys common stock on 08/15/2025 and 08/19/2025. On 08/15/2025 he received a grant of 8,957 restricted stock units (RSUs) that vest in three equal annual installments beginning 08/15/2026, increasing his beneficial holdings to 98,471 shares. Also on 08/15/2025, 30,811 shares were withheld to satisfy tax obligations related to vesting, reducing holdings to 67,660 shares. On 08/19/2025 he sold a total of 41,575 shares in multiple transactions at weighted average prices of about $147.87, $148.83, and $149.39, resulting in 26,085 shares beneficially owned after the reported sales. The Form 4 discloses price ranges and notes weighted-average pricing for those sales.

Deborah Weitzman, an officer (CEO, PSS Segment) of Cardinal Health, reported two transactions on 08/15/2025. She was granted 10,694 restricted share units (RSUs) that vest in three equal annual installments beginning 08/15/2026, increasing her beneficial ownership to 98,923 common shares. Separately, 24,128 shares were withheld to satisfy tax obligations related to the vesting of 14,966 RSUs and 39,100 performance share units, executed at a prior-business-day closing price of $150.22, leaving beneficial ownership of 74,795 common shares. The form is signed by an attorney-in-fact on 08/19/2025.

Cardinal Health CEO Jason M. Hollar reported several equity transactions in August 2025. He received 42,778 restricted share units (RSUs) on 08/15/2025 that vest in three equal annual installments beginning 08/15/2026. To satisfy tax withholding on vested awards, 136,407 shares were withheld in connection with the vesting of 61,869 RSUs and 245,420 performance share units, leaving him with 343,606 shares after that withholding. On 08/19/2025 he sold a total of 107,705 shares in multiple transactions at weighted average prices reported between $147.40 and $149.58, leaving him with 235,901 shares beneficially owned following the sales.

Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health, reported multiple equity transactions in Form 4. On 08/15/2025 she was granted 9,358 restricted share units (RSUs) that vest in three equal annual installments beginning 08/15/2026. Also on 08/15/2025 a disposition of 27,927 shares occurred to satisfy tax withholding related to the vesting of 12,969 RSUs and 49,994 performance share units, at an effective price of $150.22 (closing price on prior business day). On 08/19/2025 she sold shares in multiple transactions: 4,345 at a weighted average $148.08, 33,333 at $148.91, and 400 at $149.52. Her reported beneficial ownership decreased from 114,462 shares following the RSU grant to 48,457 shares after the reported sales and withholding.